ArticleNPJ breast cancer2024

Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.

Vaseem M Khatri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.